The Renal Denervation Market growth continues to accelerate as European healthcare systems expand reimbursement and clinical adoption following CE mark approvals and positive health technology assessments. With hypertension representing the leading modifiable cardiovascular risk factor across Europe and many countries struggling to achieve guideline-recommended blood pressure control rates, the...